RxDoctor Payments Data

Nicholas Yarrobino

Physician Assistant · Fort Worth, TXNPI 1770093635

Payments from drug & device makers

$11,097in general payments, 2019–2025

Across 342 payments — averaging $32.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$3K
  • AstraZeneca$616
  • Johnson & Johnson$516
  • Novartis$413
  • Astellas Pharma US Inc$388
  • E.r. Squibb & Sons, L.L.C.$337
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$2,50023%
  • Food & beverage$8,29275%
  • Education$3053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.27$3,244
AstraZeneca(2 entities)20$616
Johnson & Johnson24$516
Novartis20$413
Astellas Pharma US Inc11$388
E.r. Squibb & Sons, L.L.C.12$337
Merck12$323
Bristol Myers Squibb11$275
Incyte Corporation11$259
Bayer11$239
GSK9$235
Pfizer10$218
Seagen Inc.6$210
Pharmaessentia USA Corporation6$197
Stemline Therapeutics Inc.4$190
Sobi, Inc8$189
Sanofi7$185
AbbVie9$173
Takeda Pharmaceuticals U.S.A., Inc.8$173
Gilead(2 entities)7$167
Eisai Inc.9$162
Amgen4$161
Blueprint Medicines Corporation2$145
Array Biopharma Inc6$131
AVEO Pharmaceuticals, Inc.5$126
Regeneron Healthcare Solutions, Inc.4$125
Lilly USA, LLC5$106
Genmab U.S., Inc.4$106
Genentech USA, Inc.5$102
Puma Biotechnology, Inc.5$89
Mirati Therapeutics, Inc.3$74
Morphosys, US Inc.3$67
Boehringer Ingelheim3$66
Kyowa Kirin, Inc.3$63
ADC Therapeutics America, Inc.3$56
Karyopharm Therapeutics Inc.3$55
Taiho Oncology, Inc.3$55
Beone Medicines USA, Inc.3$54
Sun Pharmaceutical Industries Inc.2$53
Syndax Pharmaceuticals, Inc.2$52
Deciphera Pharmaceuticals Inc.2$51
Tactile Systems Technology Inc2$50
Geron Corporation2$44
Spectrum Pharmaceuticals Inc.2$43
Coherus Oncology, Inc.2$41
Immunocore Limited1$38
Tempus AI, Inc2$36
Adaptive Biotechnologies Corporation1$35
Foundation Medicine, Inc.1$29
Pharmacosmos Therapeutics Inc.2$28
CTI Biopharma Corp.1$26
Pharmacyclics LLC, An Abbvie Company1$26
Servier Pharmaceuticals LLC1$25
Exelixis Inc.1$21
Agios Pharmaceuticals, Inc.1$21
Caris MPI, Inc.1$21
Rigel Pharmaceuticals, Inc.1$21
Immunogen, Inc.1$21
Beigene USA, Inc.1$21
Recordati_rare_diseases_inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,097 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$18,867
Abiraterone Acetate11$1,190
Ondansetron OdtOndansetron56$852
Hydroxyurea29$655
Prochlorperazine Maleate28$266
Dexamethasone26$255
Acetaminophen-CodeineAcetaminophen With Codeine12$196
Acyclovir27$180
Anastrozole17$174
Gabapentin17$113
Levothyroxine Sodium16$103
Prednisone22$86
Alendronate Sodium11$84
Pantoprazole Sodium14$73
Alprazolam12$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$218$18,86728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →